Tags

Type your tag names separated by a space and hit enter

The ability of systemic biochemical markers to reflect presence, incidence, and progression of early-stage radiographic knee and hip osteoarthritis: data from CHECK.
Osteoarthritis Cartilage 2015; 23(8):1388-97OC

Abstract

OBJECTIVE

To relate systemic biochemical markers of joint metabolism to presence, incidence, and progression of early-stage radiographic knee and/or hip osteoarthritis (OA).

METHOD

The cartilage markers uCTX-II, sCOMP, sPIIANP, and sCS846, bone markers uCTX-I, uNTX-I, sPINP, and sOC, and synovial markers sHA and sPIIINP were assessed by enzyme-linked immunosorbent assay or radioactive immunoassay in baseline samples of CHECK (Cohort Hip and Cohort Knee), a cohort study of early-stage symptomatic knee and/or hip OA. Knee and hip radiographs were obtained at baseline and 5-year follow-up. Presence of OA at baseline was defined as Kellgren and Lawrence (K&L) = 1 (maximum observed). Incidence of OA was defined as K&L = 0 at baseline and K&L ≥ 1 at 5-year follow-up. Progression of OA was defined as K&L = 1 at baseline and K&L ≥ 2 at 5-year follow-up.

RESULTS

Data were available for 801 subjects at baseline and for 723 subjects at both baseline and 5-year follow-up. Multiple cartilage and synovial markers showed positive associations with presence and progression of knee and hip OA and with incidence of hip OA, except for negative associations of uCTX-II and sCOMP with incidence of knee OA. uCTX-II and sCOMP showed multiple interactions with other biomarkers in their associations with knee and hip OA. Bone markers were positively associated with presence of radiographic knee OA, but negatively associated with progression of radiographic hip OA.

CONCLUSION

Especially metabolism in cartilage and synovial matrix appear to be of relevance in knee and hip OA. The role of bone metabolism appears to differ between knee and hip OA.

Authors+Show Affiliations

Department of Rheumatology & Clinical Immunology, University Medical Center Utrecht, PO Box 85500, 3508 GA, Utrecht, The Netherlands. Electronic address: w.e.vanspil@umcutrecht.nl.Department of Rheumatology & Clinical Immunology, University Medical Center Utrecht, PO Box 85500, 3508 GA, Utrecht, The Netherlands. Electronic address: p.m.j.welsing@umcutrecht.nl.Department of General Practice, Department of Orthopaedics, University Medical Center Rotterdam - Erasmus Medical Center, PO Box 2040, 3000 CA, Rotterdam, The Netherlands. Electronic address: s.bierma-zeinstra@erasmusmc.nl.Department of Rheumatology & Clinical Immunology, University Medical Center Utrecht, PO Box 85500, 3508 GA, Utrecht, The Netherlands. Electronic address: j.w.j.bijlsma@umcutrecht.nl.Amsterdam Rehabilitation Research Center, Reade, PO Box 58271, 1040 HG, Amsterdam, The Netherlands. Electronic address: l.roorda@reade.nl.Sint Maartenskliniek, PO Box 9011, 6500 GM, Nijmegen, The Netherlands. Electronic address: h.cats@maartenskliniek.nl.Department of Rheumatology & Clinical Immunology, University Medical Center Utrecht, PO Box 85500, 3508 GA, Utrecht, The Netherlands. Electronic address: f.lafeber@umcutrecht.nl.

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

25819579

Citation

Van Spil, W E., et al. "The Ability of Systemic Biochemical Markers to Reflect Presence, Incidence, and Progression of Early-stage Radiographic Knee and Hip Osteoarthritis: Data From CHECK." Osteoarthritis and Cartilage, vol. 23, no. 8, 2015, pp. 1388-97.
Van Spil WE, Welsing PM, Bierma-Zeinstra SM, et al. The ability of systemic biochemical markers to reflect presence, incidence, and progression of early-stage radiographic knee and hip osteoarthritis: data from CHECK. Osteoarthr Cartil. 2015;23(8):1388-97.
Van Spil, W. E., Welsing, P. M., Bierma-Zeinstra, S. M., Bijlsma, J. W., Roorda, L. D., Cats, H. A., & Lafeber, F. P. (2015). The ability of systemic biochemical markers to reflect presence, incidence, and progression of early-stage radiographic knee and hip osteoarthritis: data from CHECK. Osteoarthritis and Cartilage, 23(8), pp. 1388-97. doi:10.1016/j.joca.2015.03.023.
Van Spil WE, et al. The Ability of Systemic Biochemical Markers to Reflect Presence, Incidence, and Progression of Early-stage Radiographic Knee and Hip Osteoarthritis: Data From CHECK. Osteoarthr Cartil. 2015;23(8):1388-97. PubMed PMID: 25819579.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - The ability of systemic biochemical markers to reflect presence, incidence, and progression of early-stage radiographic knee and hip osteoarthritis: data from CHECK. AU - Van Spil,W E, AU - Welsing,P M J, AU - Bierma-Zeinstra,S M A, AU - Bijlsma,J W J, AU - Roorda,L D, AU - Cats,H A, AU - Lafeber,F P J G, Y1 - 2015/03/26/ PY - 2014/09/20/received PY - 2015/02/23/revised PY - 2015/03/15/accepted PY - 2015/3/31/entrez PY - 2015/3/31/pubmed PY - 2016/5/5/medline KW - Biomarkers KW - Hip osteoarthritis KW - Knee osteoarthritis KW - Radiography SP - 1388 EP - 97 JF - Osteoarthritis and cartilage JO - Osteoarthr. Cartil. VL - 23 IS - 8 N2 - OBJECTIVE: To relate systemic biochemical markers of joint metabolism to presence, incidence, and progression of early-stage radiographic knee and/or hip osteoarthritis (OA). METHOD: The cartilage markers uCTX-II, sCOMP, sPIIANP, and sCS846, bone markers uCTX-I, uNTX-I, sPINP, and sOC, and synovial markers sHA and sPIIINP were assessed by enzyme-linked immunosorbent assay or radioactive immunoassay in baseline samples of CHECK (Cohort Hip and Cohort Knee), a cohort study of early-stage symptomatic knee and/or hip OA. Knee and hip radiographs were obtained at baseline and 5-year follow-up. Presence of OA at baseline was defined as Kellgren and Lawrence (K&L) = 1 (maximum observed). Incidence of OA was defined as K&L = 0 at baseline and K&L ≥ 1 at 5-year follow-up. Progression of OA was defined as K&L = 1 at baseline and K&L ≥ 2 at 5-year follow-up. RESULTS: Data were available for 801 subjects at baseline and for 723 subjects at both baseline and 5-year follow-up. Multiple cartilage and synovial markers showed positive associations with presence and progression of knee and hip OA and with incidence of hip OA, except for negative associations of uCTX-II and sCOMP with incidence of knee OA. uCTX-II and sCOMP showed multiple interactions with other biomarkers in their associations with knee and hip OA. Bone markers were positively associated with presence of radiographic knee OA, but negatively associated with progression of radiographic hip OA. CONCLUSION: Especially metabolism in cartilage and synovial matrix appear to be of relevance in knee and hip OA. The role of bone metabolism appears to differ between knee and hip OA. SN - 1522-9653 UR - https://www.unboundmedicine.com/medline/citation/25819579/The_ability_of_systemic_biochemical_markers_to_reflect_presence_incidence_and_progression_of_early_stage_radiographic_knee_and_hip_osteoarthritis:_data_from_CHECK_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S1063-4584(15)00865-1 DB - PRIME DP - Unbound Medicine ER -